Literature DB >> 16677721

Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice.

Artur H Swiergiel1, Adrian J Dunn.   

Abstract

Interleukin-6 (IL-6) has been implicated in behavioral responses associated with inflammation, sickness behavior and various nervous system disorders. We studied a range of different behaviors in IL-6-knockout (IL-6ko) and wild-type (WT) male mice. No significant differences were observed in ambulatory, exploratory, and stereotypic activities in home or novel cages, in an open field (OF), in the multicompartment chamber (MCC), or in the elevated plus-maze (EPM). IL-6ko mice shed fewer fecal boli than WT mice in the OF, in novel cages and in the MCC although this effect was not statistically significant in the OF. In novel cages, intraperitoneal (i.p.) injection of IL-6 (1 microg) depressed ambulatory activity slightly more in IL-6ko than in WT mice. Restraint and interleukin-1beta (IL-1beta, 100 ng i.p.) decreased exploration of mice in the MCC and EPM, but there was no indication of altered sensitivity in IL-6ko mice. No significant differences were detected in the tail suspension and the Porsolt forced swim tests. IL-1beta and lipopolysaccharide (LPS 1 microg i.p.) injection depressed sweetened milk and solid food intake similarly in IL-6ko and WT mice, but IL-6 had no effect, suggesting that IL-6 is not involved in these effects of IL-1 or LPS. However, IL-1beta and LPS depressed body weight more in WT than in IL-6ko mice. Plasma corticosterone and basal concentrations of catecholamines, indoleamines and their metabolites in several brain regions were similar. The responses in these measures to IL-1beta and LPS were also similar, except that there were no significant changes in tryptophan and serotonin metabolism in IL-6ko mice. This may reflect a role for IL-6 in the tryptophan and serotonin responses to IL-1 and LPS. It is concluded that the lack of IL-6 is not associated with substantial alterations in several different mouse behaviors, and in the responses to restraint, IL-1beta, IL-6 and LPS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677721      PMCID: PMC1975690          DOI: 10.1016/j.bbr.2006.03.024

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  83 in total

1.  Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.

Authors:  H Hampel; S J Teipel; F Padberg; A Haslinger; M Riemenschneider; M J Schwarz; H U Kötter; M Scheloske; K Buch; S Stübner; R Dukoff; R Lasser; N Müller; T Sunderland; S I Rapoport; H J Möller
Journal:  Brain Res       Date:  1999-03-27       Impact factor: 3.252

Review 2.  Interleukin-6: from basic science to medicine--40 years in immunology.

Authors:  Tadamitsu Kishimoto
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 3.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

4.  Role of interleukin-6 in mortality from and physiologic response to sepsis.

Authors:  Daniel G Remick; Gerald Bolgos; Shannon Copeland; Javed Siddiqui
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient mice.

Authors:  Jonathan D Morrow; Mark R Opp
Journal:  Brain Behav Immun       Date:  2005-01       Impact factor: 7.217

6.  Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation.

Authors:  Jonathan D Morrow; Mark R Opp
Journal:  Brain Behav Immun       Date:  2005-01       Impact factor: 7.217

7.  Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats.

Authors:  M J Lenczowski; R M Bluthé; J Roth; G S Rees; D A Rushforth; A M van Dam; F J Tilders; R Dantzer; N J Rothwell; G N Luheshi
Journal:  Am J Physiol       Date:  1999-03

8.  The roles of IL-1, IL-6, and TNFalpha in the feeding responses to endotoxin and influenza virus infection in mice.

Authors:  A H Swiergiel; A J Dunn
Journal:  Brain Behav Immun       Date:  1999-09       Impact factor: 7.217

9.  Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications.

Authors:  Salvatore Alesci; Pedro E Martinez; Sujata Kelkar; Ioannis Ilias; Donna S Ronsaville; Samuel J Listwak; Alejandro R Ayala; Julio Licinio; Herman K Gold; Mitchel A Kling; George P Chrousos; Philip W Gold
Journal:  J Clin Endocrinol Metab       Date:  2005-02-10       Impact factor: 5.958

10.  Mapping quantitative trait loci for anxiety in chromosome substitution strains of mice.

Authors:  Jonathan B Singer; Annie E Hill; Joseph H Nadeau; Eric S Lander
Journal:  Genetics       Date:  2004-09-15       Impact factor: 4.562

View more
  10 in total

Review 1.  Oxidative mechanisms of brain dysfunction during sepsis.

Authors:  Felipe Dal-Pizzol; Cristiane Ritter; Omar J Cassol; Gislaine T Rezin; Fabrícia Petronilho; Alexandra I Zugno; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2009-08-14       Impact factor: 3.996

2.  Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

Authors:  J C O'Connor; M A Lawson; C André; M Moreau; J Lestage; N Castanon; K W Kelley; R Dantzer
Journal:  Mol Psychiatry       Date:  2008-01-15       Impact factor: 15.992

3.  Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.

Authors:  Susan K Lutgendorf; Aliza Z Weinrib; Frank Penedo; Daniel Russell; Koen DeGeest; Erin S Costanzo; Patrick J Henderson; Sandra E Sephton; Nicolas Rohleder; Joseph A Lucci; Steven Cole; Anil K Sood; David M Lubaroff
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

Review 4.  Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology.

Authors:  Jason C O'Connor; Robert H McCusker; Klemen Strle; Rodney W Johnson; Robert Dantzer; Keith W Kelley
Journal:  Cell Immunol       Date:  2008-03-05       Impact factor: 4.868

5.  Central blockade of melanocortin receptors attenuates the metabolic and locomotor responses to peripheral interleukin-1beta administration.

Authors:  Keith W Whitaker; Teresa M Reyes
Journal:  Neuropharmacology       Date:  2007-11-05       Impact factor: 5.250

6.  High-precision genetic mapping of behavioral traits in the diversity outbred mouse population.

Authors:  R W Logan; R F Robledo; J M Recla; V M Philip; J A Bubier; J J Jay; C Harwood; T Wilcox; D M Gatti; C J Bult; G A Churchill; E J Chesler
Journal:  Genes Brain Behav       Date:  2013-03-20       Impact factor: 3.449

7.  A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment.

Authors:  He-Yang Zhang; Yan Wang; Youdi He; Ting Wang; Xiao-Hui Huang; Chang-Ming Zhao; Lei Zhang; Si-Wei Li; Changyong Wang; Yan-Nv Qu; Xiao-Xia Jiang
Journal:  J Neuroinflammation       Date:  2020-07-01       Impact factor: 8.322

8.  Evaluation of the neutrophil:lymphocyte ratio as an indicator of chronic distress in the laboratory mouse.

Authors:  Debra L Hickman
Journal:  Lab Anim (NY)       Date:  2017-06-23       Impact factor: 12.625

9.  Effects of ammonia exposure on growth performance and cytokines in the serum, trachea, and ileum of broilers.

Authors:  Ying Zhou; Qing Xiu Liu; Xiu Mei Li; Dan Dan Ma; Shuang Xing; Jing Hai Feng; Min Hong Zhang
Journal:  Poult Sci       Date:  2020-03-19       Impact factor: 3.352

10.  Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10.

Authors:  Jeffrey L Voorhees; Andrew J Tarr; Eric S Wohleb; Jonathan P Godbout; Xiaokui Mo; John F Sheridan; Timothy D Eubank; Clay B Marsh
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.